Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2017-N-0001]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice; amendment.

# SUMMARY:

                        The Food and Drug Administration (FDA) is announcing amendments to the notice of meeting of the Patient Engagement Advisory Committee. This meeting was announced in the                         **Federal Register**                         of July 26, 2017. The amendments are being made to reflect time changes in the                         **DATES**                         and                         *Procedure*                         sections and to add                         *Webcast Information*                         to the document. There are no other changes.                    

# FOR FURTHER INFORMATION CONTACT:

                        Letise Williams, Center for Devices and Radiological Health, Food and Drug                               ( print page 46251)                            Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5441, Silver Spring, MD 20993-0002, 301-796-8398; or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code PEAC. Please call the Information Line for up-to-date information on this meeting.                    

# SUPPLEMENTARY INFORMATION:

                    In the                     **Federal Register**                     of July 26, 2017 (82 FR 34681), FDA announced that a meeting of the Patient Engagement Advisory Committee would be held on October 11 and 12, 2017. On page 34681, in the third column, the                     **DATES**                     section is changed to reflect the time of these meetings on the announced dates.                

                    On page 34682, in the first column, in the                     *Procedure*                     section, the third sentence is changed to reflect new times for oral presentations on October 11 and 12.                

                    On page 34682, in the second column, a                     *Webcast Information*                     section is added before the last paragraph of the document. The amendments read as follows:                

# DATES:

The meeting will be held on October 11, 2017, from 12:30 p.m. to 6 p.m. and October 12, 2017, from 8 a.m. to 5 p.m.

*Procedure:*                         Oral presentations from the public will be scheduled between approximately 2:30 p.m. to 3 p.m. on October 11, 2017, and approximately 1 p.m. to 2:30 p.m. on October 12, 2017.                    

*Webcast Information:*                         This meeting will also be made available to the public via webcast. The links for the webcasts are below: October 11, 2017: “Patient Engagement Advisory Committee Meeting, Day 1,”                         *https://event.webcasts.com/​starthere.jsp?​ei=​1157277&​tp_​key=​5580d0c7a5.*                         October 12, 2017: “Patient Engagement Advisory Committee Meeting, Day 2,” Morning Session—                        *https://event.webcasts.com/​starthere.jsp?​ei=​1157280&​tp_​key=​dfcde848fe;​*                         and Afternoon Session—                        *https://event.webcasts.com/​starthere.jsp?​ei=​1157282&​tp_​key=​6d832a247e.*

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

Dated: September 29, 2017.

Anna K. Abram,

Deputy Commissioner for Policy, Planning, Legislation, and Analysis.

[FR Doc. 2017-21317 Filed 10-3-17; 8:45 am]

 BILLING CODE 4164-01-P